What Is New in the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes
M Roffi - Cardiology Discovery, 2023 - mednexus.org
For the first time, European Society of Cardiology (ESC) guidelines have aggregated in 1
single document recommendations for the management of patients with non-ST-segment …
single document recommendations for the management of patients with non-ST-segment …
The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis
Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and
mortality worldwide. Polypills, containing various combinations of medications for primary …
mortality worldwide. Polypills, containing various combinations of medications for primary …
[HTML][HTML] Is there a role for earlier use of combination therapy?
S Revankar, JK Park, P Satish, A Agarwala - American Journal of …, 2024 - Elsevier
As the global population ages and cardiovascular risk factors rise, we can expect a
continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) …
continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) …
The place of polypill in secondary prevention of stroke
DB Ojji, MD Huffman - The Lancet Global Health, 2023 - thelancet.com
People who have had a stroke are confronted with multiple medications and complex
treatment regimens, both associated with low adherence. As a result of barriers at the health …
treatment regimens, both associated with low adherence. As a result of barriers at the health …
Health equity and actionable disparities in stroke: 2022 update
A Towfighi, B Ovbiagele - Stroke, 2023 - Am Heart Assoc
There are stark inequities in stroke incidence, prevalence, care, and outcomes. This issue of
Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable …
Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable …
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?
J Gregson, SJ Pocock, SD Anker, DL Bhatt… - Journal of the American …, 2024 - jacc.org
During patient follow-up in a randomized trial, some deaths may occur. Where death (or
noncardiovascular death) is not part of an outcome of interest it is termed a competing risk …
noncardiovascular death) is not part of an outcome of interest it is termed a competing risk …
Assessment of Medication Adherence Using Pharmacy Data Before and After Percutaneous Coronary Intervention
SM Abera, C O'Donnell, T Salahuddin… - Patient preference …, 2023 - Taylor & Francis
Objective Adherence to anti-platelet medications is critical following coronary stenting, but
prior studies indicate that clinician assessment and patient self-assessment of adherence …
prior studies indicate that clinician assessment and patient self-assessment of adherence …
[HTML][HTML] Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting
A Yusufali, M Zidan, R Khatib, R Kelishadi… - Global …, 2024 - globalheartjournal.com
Background: Evidence-based International clinical practice guidelines, universally
recommend secondary prevention medications for those with previous cardiovascular …
recommend secondary prevention medications for those with previous cardiovascular …
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention
L De Luca, SA Di Fusco, G Iannopollo… - European Heart …, 2024 - academic.oup.com
The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention
presents a significant barrier to improving patient outcomes. To address this, the utilization of …
presents a significant barrier to improving patient outcomes. To address this, the utilization of …
Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action
C Suárez Fernández, P Armario… - Current Medical …, 2023 - Taylor & Francis
COVID-19 has had a negative impact on the health care of patients with cardiovascular
disease and patients at high risk of cardiovascular disease. The restrictions affecting access …
disease and patients at high risk of cardiovascular disease. The restrictions affecting access …